Sign up to save your podcasts
Or
Share BTK Inhibitors in Multiple Sclerosis Treatment - Part 1
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
BTK Inhibitors in Multiple Sclerosis Treatment - Part 1
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how Bruton Tyrosine Kinase (BTK) Inhibitors work and how they vary from other disease-modifying therapies.
Show reference:
https://www.nejm.org/doi/full/10.1056/NEJMoa2415985
https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
View all episodes
By American Academy of Neurology
4.8
129129 ratings
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how Bruton Tyrosine Kinase (BTK) Inhibitors work and how they vary from other disease-modifying therapies.
Show reference:
https://www.nejm.org/doi/full/10.1056/NEJMoa2415985
https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
More shows like Neurology Minute
View all
JAMA Editors' Summary
128 Listeners
Neurology® Podcast
279 Listeners
NEJM This Week
318 Listeners
Practical Neurology Podcast
34 Listeners
JAMA Clinical Reviews
480 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Medical News
91 Listeners
Neurology Today in 5
21 Listeners
Annals On Call Podcast
174 Listeners
Navigating Neuropsychology
341 Listeners
The Clinical Problem Solvers
512 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
321 Listeners
Neurology Exam Prep Podcast
179 Listeners
The Curious Clinicians
363 Listeners
Continuum Audio
73 Listeners